Monday, November 16th, 2026

Bangladesh’s first native Covid vaccine Bangavax receives nod for human trials



DHAKA: Bangladesh’s first homegrown vaccine has received approval from the Bangladesh Medical Research Council (BMRC) for human trials.

Senior manager for quality and regulation AT Directorate General of Drug Administration (DGDA) stated that the manufacturer of Bangavax, Globe Biotech is set to send DGDA human trial protocol, reported the Daily Star.

After the single-dose vaccine, Bangavax gets assent for clinical trials from DGDA, Globe Biotech will initiate human trials, said DGDA senior manager.

Globe Biotech on October 5 the previous year, revealed that its first vaccine candidate had shown promise in pre-clinical trials on mice, reported the Daily Star.

Bangavax was initially known as Bancovid. (ANI)

Publish Date : 24 November 2021 22:38 PM

Kathmandu Valley’s minimum temperature rises by 2.4 degrees Celsius in a day

KATHMANDU: The minimum temperature in the Kathmandu Valley increased by

Farmers in Ilam busy harvesting paddy as harvest season begins

ILAM: Paddy harvesting has begun in the lower belt of

NRB fixes foreign currency exchange rates for today

KATHMANDU: Nepal Rastra Bank (NRB) has fixed the foreign exchange

Western low-pressure system brings patchy clouds to Nepal’s Himalayan regions

KATHMANDU: A western low-pressure system is having a partial influence

EC invites political parties for talks on local polls

KATHMANDU: The Election Commission (EC) has invited political parties for